|Bid||61.17 x 800|
|Ask||61.18 x 800|
|Day's Range||60.96 - 61.87|
|52 Week Range||57.04 - 85.97|
|Beta (5Y Monthly)||0.55|
|PE Ratio (TTM)||60.66|
|Forward Dividend & Yield||2.72 (4.45%)|
|Ex-Dividend Date||Dec 14, 2020|
|1y Target Est||N/A|
Investors looking for dividend-paying stocks that offer juicy yields right now can find what they're looking for in the biopharmaceutical industry. All three of these big pharmaceutical companies have well-funded dividend programs that offer juicy yields above 4% right now. Since spinning off from Abbott in 2013, AbbVie has raised its dividend payout a whopping 225% with help from its top-selling rheumatoid arthritis treatment, Humira.
Biotech stocks are likely to remain in focus through year end amid news surrounding COVID-19 vaccines and treatments.
When you think about dividend stocks, biotechs probably don't immediately come to mind. Gilead Sciences' (NASDAQ: GILD) dividend program especially stands out. The company arguably offers the best dividend of any biotech.